1van Ree JM, Gerrits MA. Opioids, reward and addiction: an encounter of biology, psychology, and medicine[J]. Pharmacol Rev, 1999, 51(2):341-396.
2McBride WJ, Murphy JM, Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies[J]. Behav Brain Res, 1999, 101(2):129-152.
3Matthes HW, Maldonado R, Simonin F, et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene[J]. Nature, 1996, 383(6603):819-823.
4Sante AB, Nobre MJ, Brandao ML. Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter[J]. Behav Pharmacol, 2000, 11(7/8):583-589.
6Kiyatkin EA. Dopamine in the nucleus accumbens: cellular actions, drug- and behavior-associated fluctuations, and a possible role in an organism′s adaptive activity[J]. Behav Brain Res, 2002, 137(1/2):27-46.
7Kaplan GB, Leite-Morris KA, Joshi M, et al. Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions [J]. Brain Res, 2003, 987(1):122-125.
8Robinson TE, Berridge KC. Addiction[J]. Annu Rev Psychol, 2003, 54:25-53.
10Shim I, Kim HT, Kim YH, et al. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat [J]. Eur J Pharmacol, 2002, 443(1-3):119-124.
9M Clara SANUDO-PENA,Michelle FORCE,TSOU Kang,Gabrielle McLEMORE,Langdon ROBERTS,J Michael WALKER.多巴胺受体系统在诱发产生的大麻酚类戒断症状中不起主要作用(英文)[J].中国药理学报,1999,20(12):1121-1124.
